| Autor: |
Nobutaka, Kudo, Akihito, Tanaka, Hideki, Ishii, Yusuke, Uemura, Kensuke, Takagi, Makoto, Iwama, Ruka, Yoshida, Taiki, Ohashi, Hideki, Kawai, Yosuke, Negishi, Norio, Umemoto, Miho, Tanaka, Masato, Watarai, Naoki, Yoshioka, Itsuro, Morishima, Toshiyuki, Noda, Yukihiko, Yoshida, Yosuke, Tatami, Takashi, Muramatsu, Toshikazu, Tanaka, Hiroshi, Tashiro, Yasunobu, Takada, Hideo, Izawa, Eiichi, Watanabe, Toyoaki, Murohara |
| Rok vydání: |
2020 |
| Předmět: |
|
| Zdroj: |
Nagoya Journal of Medical Science |
| ISSN: |
2186-3326 |
| Popis: |
The outbreak of coronavirus disease 19 (COVID-19) has had a great impact on medical care. During the COVID-19 pandemic, the rate of hospital admissions has been lower and the rate of in-hospital mortality has been higher in patients with acute coronary syndrome (ACS) in Western countries. However, in Japan, it is unknown whether the COVID-19 pandemic has affected the incidence of ACS. In the study, eleven hospitals in the Tokai region participated. Among enrolled hospital, we compared the incidence of ACS during the COVID-19 pandemic (April and May, 2020) with that in equivalent months in the preceding year as the control. During the study period; April and May 2020, 248 patients with ACS were admitted. Compared to April and May 2019, a decline of 8.1% [95% confidence interval (CI) 5.2–12.1; P = 0.33] in admissions for ACS was observed between April and May 2020. There was no significant difference in the strategy for revascularization and in-hospital deaths between 2019 and 2020. In conclusion, the rate of admission for ACS slightly decreased during the COVID-19 pandemic, compared to the same months in the preceding year. Moreover, degeneration of therapeutic procedures for ACS did not occur. |
| Databáze: |
OpenAIRE |
| Externí odkaz: |
|
